Status:
RECRUITING
Sleep Length and Euploid Embryo Transfer Prospective Study
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Friends of Prentice
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-45 years
Brief Summary
Sleep is a critical component of daily life that significantly influences health and well-being. Despite the integral role sleep plays in life, its effect on women's reproductive health, and its subse...
Detailed Description
Infertility is a devastating disease affecting 1 in 8 couples in the United States and over 80 million people worldwide. Despite significant improvements in the treatments available to infertile indiv...
Eligibility Criteria
Inclusion
- Undergoing a single euploid frozen embryo transfer
- Patient's 1st, 2nd, or 3rd embryo transfer (prior fresh or frozen transfers included)
Exclusion
- Primary infertility diagnosis of polycystic ovary syndrome
- BMI \> 40
- Diagnosis of primary ovarian insufficiency (FSH \> 40)
- Night work
- High risk of poor outcomes of fertility treatment \[\> 2 prior miscarriages (women with recurrent pregnancy loss), significant uterine factor infertility \[\>/= 2 myomectomies (open abdominal or laparoscopic) or any non-hystoeroscopic myomectomy entering the endometrial cavity\]
- Undergoing medical fertility preservation for a significant medical co-morbidity
- Current cancer diagnosis
- \> 3 prior failed embryo transfers in attempt for current live birth
Key Trial Info
Start Date :
January 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06139757
Start Date
January 17 2024
End Date
July 31 2025
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611